(A) Non-parallel left shift
(B) Non-parallel right shift
(C) Parallel right shift
(D) Parallel left shift
(B) Non-parallel right shift
(C) Parallel right shift
(D) Parallel left shift
(A) Can cause a parallel shift to the right in a drug-response curve for agonist
(B) Can be reversed by increasing dose of agonist
(C) Appear to decrease the potency of the agonist
(D) All of the above
(A) Antagonism.
(B) Noncompetitive
(C) Competitive
(D) Non-competitive and competitive
(A) It determines the quantitative relations between dose or concentration of drug and pharmacologic effects.
(B) Responsible for the selectivity of drug action.
(C) Mediates the actions of pharmacological agonists and antagonists.
(D) None of the above
(A) Ionized, less plasma protein bound, lipid soluble
(B) Unionized, less plasma protein bound, lipid soluble
(C) Unionized, highly plasma protein bound, lipid soluble
(D) Unionized, highly plasma protein bound, lipid-insoluble
(A) Weak bases are absorbed efficiently across the epithelial cells of the stomach
(B) Co-administration of atropine speed up the absorption of a second drug
(C) Drugs showing a large Vd can be efficiently removed by dialysis of the plasma
(D) Weak acids are absorbed efficiently across the epithelial cells of the stomach
(A) Pharmacokinetic
(B) Pharmacodynamic
(C) Pharmacology
(D) Pharmacotherapeutics
(A) aspirin
(B) morphine
(C) streptomycin
(D) digitalis
A. Erythema multiforme
B. Lichenplanus
C. Pemphigus vulgaris
D. Psoriasis
A. pemphigus
B. Bullous pemphigoid
C. Bullous lichen planus
D. Pemphigoid